Work

Treatment through progression with ofranogene obadenovec (VB-111), an anti-cancer viral therapy, significantly attenuates tumor growth in recurrent GBM: Individual phase 2 patient data.

Year: 2017

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2017.35.15_suppl.2055

Authors: Andrew Jacob Brenner, Patrick Y. Wen, James J. Vredenburgh, Katherine B. Peters, Deborah T. Blumenthal, Laurence S Freedman, Bernice Oberman, Noa Lowenton-Spier, Michal Lavi, Dror Harats, Yael Chava Cohen

Institutions: The University of Texas at San Antonio Health Science Center, Dana-Farber Cancer Institute, Saint Francis Hospital & Medical Center, Duke Medical Center, Tel Aviv Sourasky Medical Center, Sheba Medical Center, Vascular Biogenics (Israel)

Language: English

Topic: Glioma Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2735595018

Cites:

Cited by:

Related to: 10